While there is no Options Income Blueprint Live Trading Session today, we are putting on two new positions.
We’re starting with an old favorite: CVS Health (CVS), which we’ve already successfully traded four times this year.
The company announced better-than-expected first-quarter earnings and revenue before the bell, due in part to COVID-19 vaccinations and tests brining customers into its stores. Management also raised their full-year earnings forecast.
I am recommending we sell an in-the-money put. If we are assigned shares, we will sell a call against them. If, however, the stock keeps rallying and our put expires worthless or we close early, I will be looking to trade this name again soon.
I am also recommending a covered call trade on Pfizer (PFE), which beat earnings expectations today, as well.
Management raised their full-year outlook, upping revenue expectations for the company’s COVID-19 vaccine by 73%.
Shares are only up slightly on the news as Wall Street appears to continue to doubt the long-term importance of the COVID-19 vaccine to the company’s growth and profitability. I think they are missing a tremendous opportunity and see great appreciation potential in the stock.
Therefore, I am recommending we buy shares and sell a call against them to bring in income.
CVS Health (CVS)
Current Stock Price: $79.77
Action: Sell to open the CVS May Week One (5/7) 80 Put
Current Option Price: $0.93-$0.98
Recommended Limit: Set your initial limit order at $0.95. You can go as low as $0.85 but please don’t start there and always use limit orders.
Expiration: After the close on Friday, May 7
Potential Rate of Return: 1.2% in four days, or 108% on an annualized basis, if this option expires worthless
Pfizer (PFE)
Current Stock Price: $39.92
Action:
- Buy 100 shares at market
- Sell to open the PFE May Week One (5/7) 40 Call for around $0.29
Cost Basis: $39.63
Expiration: After the close on Friday, May 7
Potential Rate of Return: 0.9% in four days, or 85% on an annualized basis, if shares are called away